shortage of tirzepatide The FDA says the Zepbound is over. That's rattling the weight loss industry FDA says years-long tirzepatide shortage

While Ozempic was initially approved to help manage type 2 diabetes by regulating blood sugar, both Ozempic (off-label) and Wegovy have demonstrated significant weight loss benefits in clinical studieseven for individuals who do not have diabetes

This is particularly relevant for patients using higher doses or those who experience pronounced appetite suppression

Many commercial protein shakes contain added sugars, which can contribute unnecessary calories and potentially affect blood glucose control in patients with diabetes

Lipogenesis is the metabolism of extra energy from carbohydrates into lipids that can be stored for future use